Latest Articles

Publication Date
Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial - Fierce Biotech

Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial Fierce Biotech

Published: March 26, 2025, 11:05 a.m.
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating - TipRanks

Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating TipRanks

Published: March 26, 2025, 10:20 a.m.
Prostate Cancer, Infertility Risks Elevated in Male Relatives of Women With POI - Endocrinology Advisor

Prostate Cancer, Infertility Risks Elevated in Male Relatives of Women With POI Endocrinology Advisor

Published: March 26, 2025, 4 a.m.
Endometriosis: assessment on O-RADS and risk of malignant transformation.

Endometriosis is a common disease, affecting approximately 10% of women of reproductive age. Several intersecting guidelines and consensus statements provide information on imaging diagnosis and surveillance strategies for endometriomas. SRU …

Published: March 26, 2025, midnight
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit - AboutLawsuits.com

Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit AboutLawsuits.com

Published: March 25, 2025, 4 p.m.
Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers - Medscape

Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers Medscape

Published: March 25, 2025, 5:52 a.m.
Tampon Test Detects Endometrial Cancer - Medscape

Tampon Test Detects Endometrial Cancer Medscape

Published: March 25, 2025, 5:52 a.m.
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer.

Endometriosis (EMS) is a chronic, gynecological condition affecting 6-10 % of reproductive-age women. While these lesions are benign, ovarian EMS presents cancer-like features, and can progress to endometriosis-correlated ovarian cancer …

Published: March 25, 2025, midnight
Mindblowing AI breakthrough can detect cancer 99% of the time - BGR

Mindblowing AI breakthrough can detect cancer 99% of the time BGR

Published: March 24, 2025, 10:33 p.m.
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer - Hoodline

University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer Hoodline

Published: March 24, 2025, 7:46 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!